Skip to main content
Displaying 13 - 16 of 16
Display:
12
24
48
Immune-Mediated and Cholestatic Diseases
5
CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
5
CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
5
CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
1
BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists - ILC 2022
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Current page
2
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy
